Montelukast increases risk of neuropsychiatric events

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2023年 / 1950卷 / 1期
关键词：
D O I：
10.1007/s40278-023-36407-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 10
相关论文
共 50 条
  • [31] Fluoroquinolone-related risk of neuropsychiatric events
    Reactions Weekly, 2024, 2031 (1) : 9 - 9
  • [32] Meta-analysis of the relationship between montelukast use and neuropsychiatric events in patients with allergic airway disease
    Mou, Yakui
    Song, Qing
    Zhao, Chunying
    Fang, Han
    Ren, Chao
    Song, Xicheng
    HELIYON, 2023, 9 (11)
  • [33] Delayed Onset of Neuropsychiatric Effects Associated with Montelukast
    Byrne, Fintan
    Oluwole, Bolarinwa
    Whyte, Vanessa
    Fahy, Sabina
    McGuinness, Delia
    IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE, 2012, 29 (02) : 125 - 127
  • [34] Montelukast, warnings about potential neuropsychiatric effects
    Reactions Weekly, 2025, 2043 (1) : 3 - 3
  • [35] Montelukast: new boxed warning on neuropsychiatric AEs
    Reactions Weekly, 2024, 1989 (1) : 6 - 6
  • [36] Neuropsychiatric side effects induced by montelukast in children
    Arslan, Z.
    ALLERGY, 2017, 72 : 561 - 562
  • [37] Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation
    Paljarvi, Tapio
    Forton, Julian
    Luciano, Sierra
    Herttua, Kimmo
    Fazel, Seena
    JAMA NETWORK OPEN, 2022, 5 (05)
  • [38] Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study
    De Greef, Julien
    Yombi, Jean Cyr
    Vincent, Anne
    Vandercam, Bernard
    de Timary, Philippe
    Boland, Lidvine
    Philippeau, Magali
    Panin, Nadtha
    Elens, Laure
    Haufroid, Vincent
    Belkhir, Leila
    JOURNAL OF INFECTIOUS DISEASES, 2025,
  • [39] Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug-gene Interaction Network
    Umetsu, Ryogo
    Tanaka, Mizuki
    Nakayama, Yoko
    Kato, Yamato
    Ueda, Natsumi
    Nishibata, Yuri
    Hasegawa, Shiori
    Matsumoto, Kiyoka
    Takeyama, Noriaki
    Iguchi, Kazuhiro
    Tanaka, Hiroyuki
    Hinoi, Eiichi
    Inagaki, Naoki
    Inden, Masatoshi
    Muto, Yoshinori
    Nakamura, Mitsuhiro
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [40] Teprotumumab increases risk of audiological events
    Reactions Weekly, 2024, 2039 (1) : 11 - 11
12345